Boehringer Ingelheim

8. Boehringer Ingelheim

Total Ad Spend: $174.7 million
Television: $119.6 million
Magazine: $54.7 million
Other: $363,740

The private company put its mouth where its money is, so to speak, talking up the two drugs that are its best sellers.

In the spotlight

Spiriva, $89.8 million
Pradaxa, $80.4 million


Boehringer Ingelheim

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.